Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equus Total Return | EQS | Nov 27, 2024 | 1.24 | +0.40 |
EQV Ventures Acquisition | EQV | Nov 27, 2024 | 9.94 | 0.00 |
Erasca | ERAS | Nov 27, 2024 | 2.92 | +5.04 |
Erayak Power Solution Group A | RAYA | Nov 27, 2024 | 1.20 | +1.69 |
Ericsson B ADR | ERIC | Nov 27, 2024 | 8.18 | -0.24 |
Erie Indemnity A | ERIE | Nov 27, 2024 | 438.12 | -0.08 |
Ermenegildo Zegna N.V. | ZGN | Nov 27, 2024 | 7.88 | +0.77 |
Ero Copper | ERO | Nov 27, 2024 | 15.26 | +0.66 |
ESAB | ESAB | Nov 27, 2024 | 128.26 | -0.36 |
Escalade | ESCA | Nov 27, 2024 | 14.99 | +0.94 |
Esco Technologies | ESE | Nov 27, 2024 | 148.09 | -0.54 |
ESGL | ESGL | Nov 27, 2024 | 1.35 | -1.46 |
ESH Acquisition | ESHA | Nov 27, 2024 | 10.68 | 0.00 |
Eshallgo | EHGO | Nov 27, 2024 | 4.00 | +1.27 |
Esperion Therapeutics | ESPR | Nov 27, 2024 | 2.54 | -1.17 |
Espey Mfg & Electronics | ESP | Nov 27, 2024 | 30.02 | -1.22 |
Esquire Financial | ESQ | Nov 27, 2024 | 78.50 | +1.63 |
ESS Tech | GWH | Nov 27, 2024 | 6.09 | +2.01 |
ESSA Bancorp | ESSA | Nov 27, 2024 | 20.48 | +1.44 |
ESSA Pharma | EPIX | Nov 27, 2024 | 1.79 | -1.11 |
Essent Group | ESNT | Nov 27, 2024 | 57.74 | -0.02 |
Essential Properties Realty Trust | EPRT | Nov 27, 2024 | 34.31 | +1.03 |
Essential Utilities | WTRG | Nov 27, 2024 | 40.28 | +0.60 |
Essex Property Trust | ESS | Nov 27, 2024 | 312.84 | +1.00 |
Establishment Labs | ESTA | Nov 27, 2024 | 46.07 | +1.10 |
Estee Lauder Companies | EL | Nov 27, 2024 | 73.96 | +1.07 |
Estrella Immunopharma | ESLA | Nov 27, 2024 | 1.04 | +2.97 |
Eterna Therapeutics | ERNA | Nov 27, 2024 | 0.44 | -6.00 |
ETFMG Alternative Harvest ETF | MJ | Nov 27, 2024 | 2.61 | +0.38 |
Ethan Allen Interiors | ETD | Nov 27, 2024 | 30.75 | +0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.